#pharmacology_drug_safety

Apixaban in Cirrhosis: Thinning Blood, Slowing Decline

Medically Reviewed by Dr. Şekip Altunkan on Nov 22, 2026.
A hepatologist explains a treatment plan to a middle-aged man with liver disease during a clinic consultation

AI-generated image · VitalsDaily

Key Takeaway

In a randomized trial of 134 adults with moderately advanced cirrhosis, adding low-dose apixaban (2.5 mg twice daily) to standard care lowered the 1-year rate of hepatic decompensation from 54.3% to 33.1%. Major bleeding was no more common with the blood thinner. Survival did not differ between the groups, and larger trials are needed before this changes routine care.

The Blood Thinner Nobody Wanted to Prescribe

Picture a 44-year-old man with a liver hardened by years of scarring. His blood tests look alarming. His clotting time is prolonged, and his platelet count is a fraction of normal. For decades, doctors read numbers like these as a warning: this patient bleeds easily, so keep blood thinners far away.

That reflex shaped how we treated cirrhosis, the condition in which scar tissue gradually replaces healthy liver cells. The moment we fear most is decompensation, when the liver can no longer keep up. Fluid floods the abdomen (ascites). Toxins the liver should clear reach the brain and cause confusion (hepatic encephalopathy). Swollen…

Medically reviewed by

Dr. Şekip Altunkan

Dr. Şekip Altunkan is an internal medicine specialist with extensive clinical experience. He trained at Hacettepe University Faculty of Medicine and later served as an Associate Professor in Internal Medicine. He founded and led the Metropol Internal Medicine and Hypertension Clinic in Ankara, pioneering non-invasive Electron Beam Tomography (EBT) cardiac imaging, arterial-stiffness measurement, and nationwide Holter monitoring. He currently practices at his private clinic in Ankara, focusing on hypertension, vascular health, cholesterol, diabetes and heart disease. He has published widely in national and international journals, serves as a peer reviewer for several international journals, and is the author of the book "Questions and Answers on Hypertension."

Share this article